Monobodies with potent neutralizing activity against SARS-CoV-2 Delta and other variants of concern

Neutralizing antibodies against the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) are useful for patients’ treatment of the coronavirus disease 2019 (COVID-19). We report here affinity maturation of monobodies against the SARS-CoV-2 spike protein and their neutralizing activity agains...

Descripción completa

Detalles Bibliográficos
Autores principales: Kondo, Taishi, Matsuoka, Kazuhiro, Umemoto, Shun, Fujino, Tomoshige, Hayashi, Gosuke, Iwatani, Yasumasa, Murakami, Hiroshi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Life Science Alliance LLC 2022
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8906176/
https://www.ncbi.nlm.nih.gov/pubmed/35256514
http://dx.doi.org/10.26508/lsa.202101322

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8906176/
https://www.ncbi.nlm.nih.gov/pubmed/35256514
http://dx.doi.org/10.26508/lsa.202101322

Ejemplares similares